EGFR and breast carcinoma: Dendrimer delivery of 5-aminolevulinic acid for protoporphyrin IX-based PDT has also been investigated in breast carcinoma cells, and targeting was achieved by attaching an EGFr-homing peptide to the dendrimer [191].